Dr Sikhulile Moyo-Deputy Laboratory Director
Dr Moyo oversees the design and implementation of the laboratory aspects of clinical trials conducted at BHP, as well as observational and surveillance studies. His interests include characterization of early HIV-1 Infection, estimating HIV incidence, evolutionary bioinformatics, phylogenetics and molecular epidemiology. He has made a number of significant recent advances in the analysis of HIV recency of infection by incorporating HIV diversity refine cross-sectional incidence estimation and over 82 peer reviewed publications. He has worked on various projects including: evaluation of point-of-care viral load and CD4 devices, early infant treatment, community-based prevention studies, Hepatitis, CMV and HPV genotyping, HIV-1 drug resistance. In 2016, he was nominated co-vice chair of the ACTG/IMPAACT Laboratory Technologist Committee.